101 related articles for article (PubMed ID: 7658357)
1. Comparison of L-carnitine pharmacokinetics with and without baseline correction following administration of single 20-mg/kg intravenous dose.
Sahajwalla CG; Helton ED; Purich ED; Hoppel CL; Cabana BE
J Pharm Sci; 1995 May; 84(5):634-9. PubMed ID: 7658357
[TBL] [Abstract][Full Text] [Related]
2. Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers.
Sahajwalla CG; Helton ED; Purich ED; Hoppel CL; Cabana BE
J Pharm Sci; 1995 May; 84(5):627-33. PubMed ID: 7658356
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(5):555-62. PubMed ID: 3234464
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of intravenously administered carnitine in haemodialysed children.
Glöggler A; Bulla M; Fürst P
J Pharm Biomed Anal; 1990; 8(5):411-4. PubMed ID: 2081201
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of L-carnitine.
Evans AM; Fornasini G
Clin Pharmacokinet; 2003; 42(11):941-67. PubMed ID: 12908852
[TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic model for L-carnitine in patients receiving haemodialysis.
Fornasini G; Upton RN; Evans AM
Br J Clin Pharmacol; 2007 Sep; 64(3):335-45. PubMed ID: 17506778
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.
Marzo A; Arrigoni Martelli E; Urso R; Rocchetti M; Rizza V; Kelly JG
Eur J Clin Pharmacol; 1989; 37(1):59-63. PubMed ID: 2591464
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
[TBL] [Abstract][Full Text] [Related]
11. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man.
Segre G; Bianchi E; Corsi M; D'Iddio S; Ghirardi O; Maccari F
Arzneimittelforschung; 1988 Dec; 38(12):1830-4. PubMed ID: 3245856
[TBL] [Abstract][Full Text] [Related]
12. Effect of dose size on the pharmacokinetics of intravenous hydrocortisone during endogenous hydrocortisone suppression.
Toothaker RD; Welling PG
J Pharmacokinet Biopharm; 1982 Apr; 10(2):147-56. PubMed ID: 7120045
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and safety of l-carnitine infused i.v. in healthy subjects.
Uematsu T; Itaya T; Nishimoto M; Takiguchi Y; Mizuno A; Nakashima M; Yoshinobu K; Hasebe T
Eur J Clin Pharmacol; 1988; 34(2):213-6. PubMed ID: 3383994
[TBL] [Abstract][Full Text] [Related]
14. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
Rebouche CJ
Ann N Y Acad Sci; 2004 Nov; 1033():30-41. PubMed ID: 15591001
[TBL] [Abstract][Full Text] [Related]
15. HPLC determination and pharmacokinetics of endogenous acetyl-L-carnitine (ALC) in human volunteers orally administered a single dose of ALC.
Kwon OS; Chung YB
Arch Pharm Res; 2004 Jun; 27(6):676-81. PubMed ID: 15283472
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and organ distribution of liposome-encapsulated L-carnitine in rats.
Jäger W; Koch HP
Arzneimittelforschung; 1993 Sep; 43(9):974-7. PubMed ID: 8240461
[TBL] [Abstract][Full Text] [Related]
17. Effects of Carnitine on Valproic Acid Pharmacokinetics in Rats.
Katayama H; Mizukami K; Yasuda M; Hatae T
J Pharm Sci; 2016 Oct; 105(10):3199-3204. PubMed ID: 27499337
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys.
Aboubakr M; Uney K; Elmas M
Br Poult Sci; 2014 Feb; 55(1):115-9. PubMed ID: 24735473
[TBL] [Abstract][Full Text] [Related]
19. Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits.
Groll AH; Mickiene D; Petraitis V; Petraitiene R; Kelaher A; Sarafandi A; Wuerthwein G; Bacher J; Walsh TJ
J Antimicrob Chemother; 2005 Nov; 56(5):899-907. PubMed ID: 16172108
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.
Suzuki A; Sakai Y; Hashimoto K; Osawa H; Tsuruoka S
Ren Fail; 2018 Nov; 40(1):196-200. PubMed ID: 29616582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]